BridgeMD
New treatment option for Solid Tumor
Official title Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology
ClinicalTrials.gov ID: NCT05306509
What this study is testing
- What it's testing
- This study aims to develop and implement a pediatric palliative care (PPC) program. It is an open-label, randomized trial (2:1 randomization) in pediatric oncology department of Children's Hospital of Fudan University.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 18
You may be able to join if
- Children within eight weeks of initial oncologic diagnosis or within eight weeks of relapse/recurrent disease diagnosis
- Children speaking Chinese
- Children's family caregivers accompanying the child in the hospital (only one family member is eligible to take this role under current hospital...
- Children's family caregivers speaking Chinese
- Health care providers who are taking care of the eligible children, including but not limited to physicians, nurses, and social workers
You likely can't join if
- \- Children who, in the opinion of their physician, are not capable mentally or verbally of participating in the survey or interview
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Minhang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Minhang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.